Conditions: Uveitis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 31
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the safety and efficacy of Adalimumab in uveitis.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Adalimumab
Intervention descriptions: intervention 1: 40 mg delivered every 2 weeks by subcutaneous injection

Protocol document: